Hashimoto Makoto
Department of Cardiovascular Surgery, Sapporo Cardiovascular Clinic, Sapporo, Japan.
Kyobu Geka. 2022 Jul;75(7):569-575.
Robot-assisted cardiac surgery offers the most minimally-invasive approach to the surgical treatment of valvular heart disease and coronary artery disease. However, robot-assisted cardiac surgery is still far from being a standardized operation. We believe that with developing robotic technology, in the near future, robotic surgery will certainly play a key role in the field of cardiac surgery, thus tips and pitfalls for introducing robotic cardiac surgery and techniques of it should be described in more detail. After two years of our experience, we have performed about 200-cases of robot-assisted cardiac surgery, including robot-assisted mitral valve repair and minimally invasive coronary artery bypass grafting (CABG). The safety and reliability of those procedures have been well described from outside Japan. However, in Japan, we are still standing at the dawn of the robot-assisted cardiac surgery era, thus various experiences should be published from each institution where the robot-assisted cardiac surgery has already standarized. Here we present our experiences and recent technical consideration of robot-assisted cardiac surgery using the da Vinci Xi surgical system.
机器人辅助心脏手术为瓣膜性心脏病和冠状动脉疾病的外科治疗提供了最微创的方法。然而,机器人辅助心脏手术仍远未成为一种标准化手术。我们相信,随着机器人技术的发展,在不久的将来,机器人手术必将在心脏外科领域发挥关键作用,因此应更详细地描述引入机器人心脏手术的技巧和陷阱。经过两年的实践经验,我们已经进行了约200例机器人辅助心脏手术,包括机器人辅助二尖瓣修复和微创冠状动脉旁路移植术(CABG)。日本以外的地区已经对这些手术的安全性和可靠性进行了充分描述。然而,在日本,我们仍处于机器人辅助心脏手术时代的开端,因此,每个已经将机器人辅助心脏手术标准化的机构都应发表各种经验。在此,我们介绍使用达芬奇Xi手术系统进行机器人辅助心脏手术的经验和近期技术考量。